Skip to content

Cardiac Rehab for Advanced Heart Failure-LVAD Candidates

A Prospective Trial to Evaluate the Utility of Focused Frailty Interventions on Patients Undergoing Evaluation for Left Ventricular Assist Device (LVAD) Placement

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03132441
Enrollment
0
Registered
2017-04-27
Start date
2017-04-30
Completion date
2018-02-28
Last updated
2018-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

advanced heart failure, NYHA Class III-IV, frailty, cardiac rehabilitation

Brief summary

This study is a pilot study evaluating the feasibility and early efficacy of cardiac rehabilitation to improve frailty and symptoms in patients with advanced heart failure (NYHA class III-IV), who are being considered for LVAD therapy.

Detailed description

Frailty in patients with advanced heart failure is not thoroughly described, but in those studies that assessed frailty, it was a common phenomenon. Furthermore, some data suggest an association between pre-LVAD implant frailty and post-implant complications and survival. Interventions for frailty have been utilized in various populations, including the elderly frail and the frail from cardiovascular causes. These interventions target physical strengthening and endurance and have been shown on occasion to improve functional outcomes. The current study, a pilot study, seeks to assess frailty in a prospective cohort of patients being evaluated in Heart Failure Clinic for consideration of LVAD implantation due to NYHA class III-IV dyspnea and enroll these patients in a six-week focused cardiac rehabilitation protocol aimed at improving frailty and functional independence. The primary endpoint of the study is improvement in frailty markers at the end (gait speed, handgrip strength), and secondary endpoints include improvement in the indices of quality of life and symptomatology via validated questionnaires.

Interventions

OTHERStrength Training for Frailty

Cardiac Rehabilitation, abbreviated course

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Single arm pilot study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Candidate for a Left Ventricular Assist Device (LVAD) * Advanced Heart Failure as determined by New York Heart Association classification III or IV

Exclusion criteria

* Unable to perform physical activities required by protocol due to anatomic or musculoskeletal comorbidities * Physical activity is contraindicated

Design outcomes

Primary

MeasureTime frameDescription
Change in frailty marker handgrip strengthBaseline, 6 weeksFrailty is assessed by the strength of a participant's handgrip, measured using a commercial device.
Change in frailty marker gait speedBaseline, 6 weeksFrailty is assessed by the strength of a participant's gait speed, measured using a commercial device.

Secondary

MeasureTime frameDescription
Change in New York Heart Association (NYHA) classificationBaseline, 6 weeksNew York Heart Association (NYHA) Classification Scale Early-Stage Heart Failure * NYHA Class I No symptoms at any level of exertion and no limitation in ordinary physical activity. * NYHA Class II Mild symptoms and slight limitation during regular activity. Comfortable at rest. Advanced-Stage Heart Failure * NYHA Class III Noticeable limitation due to symptoms, even during minimal activity. Comfortable only at rest. * NYHA Class IV Severe limitations. Experience symptoms even while at rest (sitting in a recliner or watching TV).
Change in Minnesota Living with Heart Failure (MLHF) scoreBaseline, 6 weeksA participant's quality of life assessed by Minnesota Living with Heart Failure (MLHF) questionnaire score.
Change in KCCQ scoreBaseline, 6 weeksA participant's quality of life assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ) questionnaire score.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026